American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1381)
  9. Gastrointestinal Oncology Service (1356)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (79)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (303)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (12)

More Publications

Results (9195)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pansarcoma analysis of cyclin-dependent kinase and cyclin outlier gene expression highlights CDK7 as a potential therapeutic target in chordoma
    Journal Article

    Lefler, D. S.; Elliott, A.; Jiang, W.; Martinez-Outschoorn, U.; Al-Sabah, J.; Freed, D. M.; King, C. M.; Maki, R. G.; Riedel, R. F.; Modiano, J. F.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Minimum technical preanalytical, patient, and clinical context data elements for cerebrospinal fluid liquid biopsy: Recommendations for public database submissions
    Journal Article

    Bagley, S. J.; Beaubier, N.; Balaj, L.; Bettegowda, C.; Carpenter, E.; Carter, B. S.; Corner, A.; Dittamore, R.; Grossman, R. L.; Hickman, R. A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • AlphaMissense for identifying pathogenic missense mutations in DNA damage repair genes in cancer
    Journal Article

    Yazaki, S.; Pei, X.; Powell, S.; Khan, A.; Setton, J.; Riaz, N.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Establishing interventional radiology in a low-resource setting: Lessons from Obafemi Awolowo University Teaching Hospitals Complex, Nigeria
    Journal Article

    Omisore, A. D.; Odedeyi, A. A.; Famurewa, O. C.; Aderibigbe, A. S.; Akinsulore, R. Y.; Adeyemi, F. M.; Adisa, A. F.; Orji, E. C.; Ayeni, A. I.; Towoju, A. G.; more...
    JCO Global Oncology (2025)

    Fulltext@MSK | Save
  • Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T
    Meeting Abstract

    Cascone, T.; Awad, M. M.; Spicer, J.; He, J.; Lu, S.; Tanaka, F.; Cornelissen, R.; Petruzelka, L. B.; Ito, H.; De Oliveira Koch, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III-IV melanoma: Primary results from RELATIVITY-098
    Meeting Abstract

    Long, G. V.; Ascierto, P. A.; Guo, J.; Chandra, S.; Tarhini, A. A.; Couselo, E. M.; Del Vecchio, M.; De Melo, A. C.; Gogas, H.; Dummer, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304
    Meeting Abstract

    Rudin, C. M.; Mountzios, G. S.; Sun, L.; Cho, B. C.; Demirci, U.; Baka, S.; Gumus, M.; Lugini, A.; Ciuleanu, T. E.; Ahn, M. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes
    Meeting Abstract

    Attard, G.; Agarwal, N.; Graff, J. N.; Sandhu, S.; Efstathiou, E.; Özgüroğlu, M.; de Santana Gomes, A. J. P.; Vianna, K. C. M.; Luo, H.; Cheng, H. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
    Meeting Abstract

    Mahner, S.; Heitz, F.; Salehi, S.; Reuss, A.; Guyon, F.; Du Bois, A.; Harter, P.; Fotopoulou, C.; Querleu, D.; Mosgaard, B. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses
    Meeting Abstract

    Elez, E.; Yoshino, T.; Shen, L.; Lonardi, S.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save